Association of Community Cancer Centers announces award recipients
The Association of Community Cancer Centers will present awards to three oncology professionals at its 36th National Oncology Conference, which will be held Oct. 30 to Nov. 1 in Orlando.
Ethan Basch, MD, MSc, director of the cancer outcomes research program at UNC Lineberger Comprehensive Cancer Center and professor in the division of hematology and oncology at UNC School of Medicine, will receive the Clinical Research Award. The award recognizes individuals whose research has significantly and positively affected patients, their families or the community.
Basch will speak at the conference about how collecting patient-reported outcomes as part of routine practice can enhance clinical care. He will discuss significant findings from his research, including how information gleaned from patient-reported outcomes can improve survival.
Arti Hurria, MD, FASCO, will be honored posthumously with the ACCC Annual Achievement Award, which recognizes distinguished individuals or organizations who have reflected the value of community cancer care through their outstanding contributions.
Hurria — who served as George Tsai family chair in geriatric oncology and director of Center for Cancer and Aging at City of Hope, as well as HemOnc Today ’s geriatric oncology section editor — died last fall in a motor vehicle accident.
William Dale, MD, PhD, chair of City of Hope’s department of supportive care medicine and a co-principal investigator with Hurria on a 5-year, $2 million grant from National Institute of Aging, will accept the award on her behalf.
Dale will provide attendees with an update on the ongoing research, as well as the benefits of performing a comprehensive geriatric assessment to better address the unique needs of older patients.
Paul D. Hansen, MD, FACS, a liver and pancreas surgeon at Providence St. Joseph Health in Oregon, will receive the David King Community Clinical Scientist Award. The award recognizes active community clinical research leaders who demonstrated leadership in the development, participation and evaluation of clinical studies, or who are active in the development of new screening, risk assessment, treatment or supportive care programs for patients with cancer.
Hansen will discuss his research into minimally invasive approaches to major pancreas and liver surgery, including how this approach can improve quality of care and reduce costs.